• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SD filed by Inogen Inc

    5/29/25 4:43:27 PM ET
    $INGN
    Industrial Specialties
    Health Care
    Get the next $INGN alert in real time by email
    SD 1 ingn_form_sd_2024.htm SD SD

     

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM SD

    SPECIALIZED DISCLOSURE REPORT

     

    INOGEN, INC.

    (Exact name of registrant as specified in its charter)

     

     

    Delaware

     

    001-36309

     

    33-0989359

    (State or other jurisdiction

    of incorporation)

     

    (Commission

    File Number)

     

    (IRS Employer

    Identification No.)

     

    859 Ward Drive, Goleta, CA

     

    93111

    (Address of principal executive offices)

     

    (Zip Code)

     

    Michael Bourque

    Executive Vice President,

    Chief Financial Officer, and Treasurer

    (805) 562-0500

    (Name and telephone number, including area code, of the person to contact in connection with this report.)

     

    Check the appropriate box to indicate the rule pursuant to which this form is being filed, and provide the period to which the information in this form applies:

    ☒ Rule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2024.

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     


     

    Section 1 - Conflict Minerals Disclosure

    Item 1.01 Conflict Minerals Disclosure and Report

    For the reporting period from January 1, 2024 to December 31, 2024, Inogen, Inc. (the “Company”) evaluated its current products and determined that certain “conflict minerals,” as defined in Section 1, Item 1.01(d)(3) of Form SD, are necessary to the functionality or production of products manufactured by the Company, which are referred to in this Form SD as “necessary conflict minerals.” Accordingly, the Company conducted a reasonable country of origin inquiry to determine whether during 2024 its necessary conflict minerals originated in the Democratic Republic of the Congo or certain adjoining countries, which are referred to in this Form SD collectively as the “covered countries.” The Company then conducted due diligence designed to conform to the Organisation for Economic Co-operation and Development (“OECD”) Due Diligence Guidance for Responsible Supply Chains of Minerals from Conflict-Affected and High-Risk Areas in order to determine whether any of the Company’s necessary conflict minerals originated from any of the covered countries and whether these conflict minerals benefited, directly or indirectly, armed groups in any of the covered countries.

    Conflict Minerals Disclosure

    In accordance with Rule 13p-1 promulgated under the Securities Exchange Act of 1934, as amended, and this Specialized Disclosure Report on Form SD, the Company is filing a Conflict Minerals Report as Exhibit 1.01 hereto. A copy of this Form SD and the Conflict Minerals Report are publicly available at http://investor.inogen.com/.

    Item 1.02 Exhibit

    In accordance with Rule 13p-1, and Items 1.01 and 1.02 of Form SD, the Company is filing its Conflict Minerals Report as Exhibit 1.01 to this Form SD.

    Section 2 – Exhibits

    Item 2.01 Exhibits

    The following exhibit is filed as part of this Form SD.

     

    Exhibit No.

     

    Description

    1.01

     

    Inogen, Inc. Conflict Minerals Report as required by Items 1.01 and 1.02 of this Form SD.

     

     


     

    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the duly authorized undersigned.

     

     

    INOGEN, INC.

    (Registrant)

     

    Date: May 29, 2025

    By:

    /s/ Michael Bourque

    Michael Bourque

    Executive Vice President,

    Chief Financial Officer

    Treasurer

    (Principal Financial and Accounting Officer)

     

     


    Get the next $INGN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $INGN

    DatePrice TargetRatingAnalyst
    6/16/2025$14.00Buy
    B. Riley Securities
    5/22/2025$12.00Hold → Buy
    Needham
    2/15/2024Mkt Perform → Outperform
    William Blair
    8/8/2023$15.00 → $8.00Overweight → Neutral
    JP Morgan
    7/14/2023Buy → Hold
    Needham
    1/17/2023Outperform → Mkt Perform
    William Blair
    12/9/2021$47.00Hold → Buy
    Needham
    11/8/2021$70.00 → $40.00Hold
    Stifel
    More analyst ratings

    $INGN
    SEC Filings

    See more
    • SEC Form SD filed by Inogen Inc

      SD - Inogen Inc (0001294133) (Filer)

      5/29/25 4:43:27 PM ET
      $INGN
      Industrial Specialties
      Health Care
    • SEC Form S-8 filed by Inogen Inc

      S-8 - Inogen Inc (0001294133) (Filer)

      5/20/25 4:27:39 PM ET
      $INGN
      Industrial Specialties
      Health Care
    • Inogen Inc filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

      8-K - Inogen Inc (0001294133) (Filer)

      5/19/25 4:38:34 PM ET
      $INGN
      Industrial Specialties
      Health Care

    $INGN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • B. Riley Securities initiated coverage on Inogen with a new price target

      B. Riley Securities initiated coverage of Inogen with a rating of Buy and set a new price target of $14.00

      6/16/25 7:50:27 AM ET
      $INGN
      Industrial Specialties
      Health Care
    • Inogen upgraded by Needham with a new price target

      Needham upgraded Inogen from Hold to Buy and set a new price target of $12.00

      5/22/25 8:16:14 AM ET
      $INGN
      Industrial Specialties
      Health Care
    • Inogen upgraded by William Blair

      William Blair upgraded Inogen from Mkt Perform to Outperform

      2/15/24 6:28:38 AM ET
      $INGN
      Industrial Specialties
      Health Care